Prosecution Insights
Last updated: April 19, 2026

Generoath Co. Ltd.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18246575 METHODS OF TREATING NEURONAL DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR miR-142 AND COMPOSITIONS THEREOF GOMEZ RODRIGUEZ, JULIO WASHINGTON 1637 Non-Final OA Mar 24, 2023
18245248 Method for Preparing Stem Cells Having Improved Engraftment Capability BARRERA, IMMACULADA 1671 Final Rejection Mar 14, 2023
16819998 VECTORS CONTAINING AIMP2-DX2 AND TARGET NUCLEIC ACIDS FOR miR 142 AND USES THEREOF SHIN, DANA H 1635 Non-Final OA Mar 16, 2020

Managing Generoath Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month